Search Results - Bee, V.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, her2-positive early breast cancer: Results from the BCIRG 006 study

    Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, her2-positive early breast cancer... by Au, H., Eiermann, W., Robert, N., Pienkowski, T., Crown, J., Martin, M., Pawlicki, M., Chan, Arlene, Mackey, J., Glaspy, J., Pintér, T., Liu, M., Fornander, T., Sehdev, S., Ferrero, J., Bée, V., Santana, M., Miller, D., Lalla, D., Slamon, D.

    Published 2013
    Get full text
  2. 2
    Adjuvant trastuzumab in HER2-positive breast cancer.

    Adjuvant trastuzumab in HER2-positive breast cancer. by Slamon, D., Eiermann, W., Robert, N., Pienkowski, T., Martin, M., Press, M., Mackey, J., Glaspy, J., Chan, Arlene, Pawlicki, M., Pinter, T., Valero, V., Liu, M., Sauter, G., von Minckwitz, G., Visco, F., Bee, V., Buyse, M., Bendahmane, B., Tabah-Fisch, I., Lindsay, M., Riva, A., Crown, J., Breast, C.

    Published 2011
    Get full text

Search Tools: